The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual.
Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.
Binge Eating Disorder according to DSM-5 criteria
18-65 years of age
Fluent Danish speaker
Concurrent psychotherapeutic treatment
Use of weight loss medications within the last month (i.e., GLP-1 receptor antagonists)
Suicidal ideation or suicidality
Psychosis or psychotic disorders
Herlev and Gentofte Hospital
Lead sponsor
Jascha Fonden
Collaborator
BETA-HEALTH Foundation
Collaborator
Mental Health Centre Ballerup
Collaborator
Region Capital Denmark
Collaborator
University of Copenhagen
Collaborator